Ms. Sana Alajmovic, Co-Founder, CEO. Board member Sana Alajmovic is Co-Founder and Chief Executive Officer of Sigrid Therapeutics AB, with successful experience in commercializing research and discovery by establishing partnerships with global top tier biopharmaceutical actors. Sana Alajmovic was selected as Top 10 Under 40 of 2019 by Genetic Engineering News (GEN) as well as Biospace 10 Life Science Innovators Under 40 to Watch in 2019. She was named one of Sweden’s 101 Super Talents by the leading Swedish business magazine Veckans Affärer in 2012.
Agenda & focus sessions 2022